Arcus Biosciences retweeted
In this #TopRead article, Dr. Christine Bowman and her team at @arcusbio provide a mechanistic rationale for CD39 inhibition to promote antitumor immunity via the enhancement of eATP-driven myeloid cell activation of T cells. Learn more in The JI: ow.ly/9gz150XAbip.
Arcus Biosciences retweeted
As Arcus chase Merck's belzutifan in the HIF-2α space, can casdatifan live up to its preclinical promise and translate some nice features into robust lasting benefits?
We take a look at the latest evidence: bit.ly/4dXqviz
Arcus Biosciences retweeted
Did you miss yesterday's #ASCOPlenarySeries session highlighting the utility of TIGIT inhibition in #NSCLC?
Watch the recording here ➡️ fal.cn/3uCrI #lcsm #immunoonc @OncoAlert @MLJohnsonMD2 @marinagarassino @wolchokj @peters_solange
Arcus Biosciences retweeted
#FactFriday: in the United States, 1 in 17 people will be diagnosed with #lungcancer in their lifetime. November is #LungCancerAwarenessMonth. Know the facts, share the facts, and spread the word to raise much needed awareness. #LCAM https://xitter.gq/t.co/EA18b0off5 #lcsm
Arcus Biosciences retweeted
Screening saves lives.
If you have the qualifying risk factors, getting screened can help address issues early while they’re easier to cure.
Visit the link below for more information on early detection:
https://xitter.gq/t.co/UYUqtXNgve
#GO2ForLungCancer #LCAM
Arcus Biosciences retweeted
#LungCancerAwarenessMonth starts today! How can you make a difference? Step 1: Share this video. #LCAM #LCSM
Arcus Biosciences retweeted
Today is #WorldCancerResearchDay. The AACR is proud to work with organizations and individuals around the world to advance cancer science. We are excited to be part of this global initiative to propel progress against cancer. Learn more: https://xitter.gq/t.co/w0Ka8m9R4t #ResearchWorks












